Balloon pulmonary angioplasty – efficient therapy of chronic thromboembolic pulmonary hypertension in the patient with advanced sarcoidosis – a case report

Table 1 Clinical and hemodynamical assessment before and after 2 BPA sessions

	Before treatment	At 12 months follow-up
WHO functional class	IV	II
NT-pro-BNP level (pg/ml)	6239	281
6MWT distance (m)	100	405
TRPG (mmHg)	95	31
RVSP (mmHg)	102	53
TAPSE (mm)	14	20
AcT (ms)	63	100
mPAP (mmHg)	54	27
CI (l/min/m²)	2.08	3.34
RAP (mmHg) systolic/diastolic/mean	14/10/9	5/3/1
PVR (Wood Units)	13.5	3.7

NT-pro-BNP natriuretic peptide concentration, 6MWT 6 min walk test, TRPG tricuspid regurgitation peak gradient, RVSP right ventricle systolic pressure, TAPSE tricuspid annular plane excursion, AcT acceleration time, mPAP mean pulmonary artery pressure, CI cardiac index, RAP right atrial pressure, PVR pulmonary vascular resistance, BPA balloon pulmonary angioplasty

ISSN: 1471-2466